Europe Point-of-care Glucose Testing Market Size & Outlook
Europe point-of-care glucose testing market, 2018-2030 (US$M)
Related Markets
Europe point-of-care glucose testing market highlights
- The Europe point-of-care glucose testing market generated a revenue of USD 952.8 million in 2023.
- The market is expected to grow at a CAGR of 3.8% from 2024 to 2030.
- In terms of segment, accu-chek inform ii was the largest revenue generating product in 2023.
- Freestyle Lite is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, Italy is expected to register the highest CAGR from 2024 to 2030.
Europe data book summary
| Market revenue in 2023 | USD 952.8 million |
| Market revenue in 2030 | USD 1,237.1 million |
| Growth rate | 3.8% (CAGR from 2023 to 2030) |
| Largest segment | Accu-chek inform ii |
| Fastest growing segment | Freestyle Lite |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Accu Check Aviva Meter, Onetouch Verio Flex, I-STAT, Freestyle Lite, Bayer CONTOUR blood glucose monitoring system, True Metrix, Accu-Chek Inform II, StatStrip |
| Key market players worldwide | Roche, Abbott Laboratories, Nipro Corp, Nova Biomedical, ACON Laboratories, Bayer AG, EKF Diagnostics Holdings PLC |
Other key industry trends
- In terms of revenue, Europe region accounted for 28.0% of the global point-of-care glucose testing market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 1,070.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Point-of-Care Glucose Testing Market Scope
Point-of-Care Glucose Testing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Europe point-of-care glucose testing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to point-of-care glucose testing market will help companies and investors design strategic landscapes.
Accu-chek inform ii was the largest segment with a revenue share of 19.52% in 2023. Horizon Databook has segmented the Europe point-of-care glucose testing market based on accu check aviva meter, onetouch verio flex, i-stat, freestyle lite, bayer contour blood glucose monitoring system, true metrix, accu-chek inform ii, statstrip covering the revenue growth of each sub-segment from 2018 to 2030.
Rising burden of diabetes along with increasing demand for rapid diagnostic tools for diabetes management in the region is a key factor driving the Europe POC glucose testing market. Local players in Europe have diverse product portfolios, which has significantly contributed to its revenue in 2019. For instance, HemoCue AB is a POC diagnostics company, situated in Sweden, offering POC testing solutions for better management of diabetes.
Reasons to subscribe to Europe point-of-care glucose testing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe point-of-care glucose testing market databook
-
Our clientele includes a mix of point-of-care glucose testing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe point-of-care glucose testing market , including forecasts for subscribers. This continent databook contains high-level insights into Europe point-of-care glucose testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Europe point-of-care glucose testing market size, by country, 2018-2030 (US$M)
Europe Point-of-Care Glucose Testing Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
